RISBZ4 Antibody

Shipped with Ice Packs
In Stock

Description

Molecular Characterization of RISBZ4

RISBZ4 (OsbZIP15) is encoded by the locus LOC_Os02g07840 in rice (Oryza sativa). Key molecular features include:

FeatureDescription
Protein length279 amino acids (837 bp ORF)
Domain architectureContains a conserved bZIP domain for DNA binding and dimerization
Expression patternUniversal expression with enhanced activity in developing seeds
HomologyShares structural similarity with other seed-specific bZIPs like OsbZIP58

This transcription factor binds to ACGT-containing promoter elements of starch synthesis genes, as demonstrated through yeast one-hybrid assays .

Functional Role in Seed Development

RISBZ4 regulates starch biosynthesis pathways by:

  • Co-activating starch synthase genes: Collaborates with OsbZIP58 and OsbZIP33 to modulate amylose/amylopectin ratios .

  • Influencing grain quality: Mutations in homologous proteins (e.g., osbzip58) alter starch chain length distribution and reduce total starch content by 12–15% .

  • Coordinating stress responses: bZIP transcription factors integrate metabolic and environmental signals during seed maturation .

Antibody Development and Validation

While no commercial RISBZ4-specific antibodies are documented, antibody characterization pipelines for plant transcription factors typically involve:

  • Immunogen design: Recombinant protein fragments corresponding to conserved bZIP domains .

  • Validation benchmarks:

    • Western blotting against knockout mutants (e.g., osbzip58 lines showing 20–30% reduced starch content)

    • Chromatin immunoprecipitation (ChIP) to confirm DNA binding specificity

    • Immunohistochemistry in developing seeds

Research Applications

RISBZ4 antibodies enable:

  • Mechanistic studies: Elucidating transcriptional networks controlling starch metabolism (e.g., altered expression of Wx and SBE1 genes in mutants) .

  • Crop improvement: Screening rice variants for optimized starch composition (e.g., mutants with DP6–DP11 chain enrichment in amylopectin) .

  • Comparative genomics: Cross-species analysis of bZIP function in wheat (TaSPA) and barley (HvBLZ2) .

Challenges and Future Directions

Current limitations include:

  • Antibody specificity: Polyclonal antibodies may cross-react with homologous bZIP proteins (e.g., RISBZ1/OsbZIP58) .

  • Validation standards: Only 54–77% of commercial antibodies demonstrate consistent performance across applications like Western blotting and immunoprecipitation .

Emerging solutions involve recombinant antibody technologies showing 25–40% higher specificity compared to traditional monoclonal formats .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RISBZ4 antibody; BZIP15 antibody; RITA-2 antibody; Os02g0175100 antibody; LOC_Os02g07840 antibody; OJ1077_E05.6 antibody; OsJ_05580 antibody; OSJNBa0073A21.32 antibody; bZIP transcription factor RISBZ4 antibody; Rice seed bZIP4 antibody; bZIP transcription factor 15 antibody; OsbZIP15 antibody
Target Names
RISBZ4
Uniprot No.

Target Background

Function
RISBZ4 Antibody targets a putative transcription factor that binds to the specific DNA sequence 5'-TGAGTCA-3'. This sequence is found in the promoter regions of genes encoding seed storage proteins.
Database Links

KEGG: osa:4328469

STRING: 39947.LOC_Os02g07840.1

UniGene: Os.1502

Subcellular Location
Nucleus.

Q&A

Basic Research Questions

  • What is RISBZ4 and what is its functional role in rice biology?

RISBZ4 belongs to the basic leucine zipper (bZIP) family of transcription factors in rice (Oryza sativa). As a bZIP transcription factor, it contains a characteristic domain composed of a basic region responsible for DNA binding and a leucine zipper region that mediates dimerization with other proteins. RISBZ4 plays important roles in regulating gene expression during seed development, particularly in the endosperm, and may be involved in abiotic stress responses.

bZIP transcription factors in rice regulate various cellular processes including seed maturation, flower development, pathogen defense, and stress signaling. Many bZIP factors respond to abscisic acid (ABA), a phytohormone involved in seed dormancy, germination, and stress responses. Research shows that bZIP transcription factors are upregulated during ABA signaling and water stress conditions, with key families including bZIP, NAC, and MYB showing the highest responsiveness . The bZIP proteins preferentially bind to specific DNA sequences to regulate these processes in plants.

  • How are RISBZ4 antibodies generated and validated for research applications?

RISBZ4 antibodies can be generated through several approaches, with each method offering distinct advantages:

Polyclonal antibodies:

  • Generated by immunizing animals (typically rabbits or chickens) with purified recombinant RISBZ4 protein or synthetic peptides from unique RISBZ4 regions

  • Result in a mixture of antibodies recognizing different epitopes on RISBZ4

  • Provide high sensitivity but may have higher cross-reactivity with related bZIP factors

Monoclonal antibodies:

  • Produced by immunizing mice followed by isolation of B cells that produce RISBZ4-specific antibodies

  • These B cells are fused with myeloma cells to create hybridomas that secrete a single antibody type

  • Offer higher specificity but potentially lower sensitivity than polyclonal antibodies

Rigorous validation of RISBZ4 antibodies should include:

  • Western blot analysis with recombinant RISBZ4 protein and plant extracts

  • Testing for cross-reactivity with other rice bZIP transcription factors

  • Immunoprecipitation followed by mass spectrometry to confirm identity

  • Use of RISBZ4 knockout/knockdown rice plants as negative controls

  • Immunohistochemistry to verify expected subcellular localization (primarily nuclear)

  • What experimental techniques can be used to detect and localize RISBZ4 protein using antibodies?

Several antibody-based techniques can effectively detect and localize RISBZ4 protein in research settings:

Western blotting:

  • Allows detection of RISBZ4 based on molecular weight (~42 kDa)

  • Provides semi-quantitative information about protein levels

  • Can be enhanced using chemiluminescent or fluorescent detection systems

Immunoprecipitation (IP):

  • Enables isolation of RISBZ4 from complex protein mixtures

  • Can be used to study protein-protein interactions (Co-IP)

  • Often combined with mass spectrometry for interaction partner identification

Immunohistochemistry (IHC) and Immunofluorescence (IF):

  • Visualizes the spatial distribution of RISBZ4 in tissue sections or cells

  • Can determine subcellular localization (expected to be predominantly nuclear)

  • May reveal tissue-specific or developmental expression patterns

Chromatin Immunoprecipitation (ChIP):

  • Identifies genomic regions bound by RISBZ4 in vivo

  • When combined with sequencing (ChIP-seq), provides genome-wide binding profiles

  • Helps elucidate target genes and regulatory networks

Enzyme-Linked Immunosorbent Assay (ELISA):

  • Enables quantitative measurement of RISBZ4 protein levels

  • Can be adapted for high-throughput analysis of multiple samples

  • Requires careful optimization of antibody concentrations

Each technique requires specific optimization for RISBZ4 detection, considering factors such as sample preparation, antibody dilution, incubation conditions, and appropriate controls.

  • What are the optimal storage and handling conditions for RISBZ4 antibodies?

Proper storage and handling of RISBZ4 antibodies are crucial for maintaining their activity and specificity over time:

Storage recommendations:

  • Long-term storage: -20°C (for most antibody formats) or -80°C (for extended preservation)

  • Working aliquots: 4°C for 1-2 weeks (to avoid repeated freeze-thaw cycles)

  • Most antibody solutions contain glycerol (30-50%) as a cryoprotectant

  • Some antibodies may include carrier proteins (BSA) for stability

Handling guidelines:

  • Thaw frozen antibodies completely at 4°C before use

  • Mix gently by inversion or mild vortexing (avoid vigorous shaking)

  • Use sterile techniques and wear gloves to prevent contamination

  • Centrifuge briefly before opening to collect all liquid at the bottom of the tube

  • Return to appropriate storage conditions immediately after use

Stability considerations:

  • Document freeze-thaw cycles (limit to 5 or fewer if possible)

  • Monitor antibody performance over time using positive controls

  • Consider adding preservatives (0.02% sodium azide) for antibodies stored at 4°C

  • Label all aliquots with antibody details, concentration, and preparation date

Storage buffer composition can significantly impact stability:

  • pH typically maintained between 6.5-8.0

  • Salt concentration (usually 150 mM NaCl) helps maintain antibody structure

  • Additives like BSA (0.1-1%) can prevent adsorption to tube walls

Following these guidelines ensures maximum antibody performance and extends the useful life of valuable RISBZ4 antibody reagents.

Advanced Research Questions

  • How can ChIP-seq be optimized when using RISBZ4 antibody for genome-wide binding studies?

Optimizing Chromatin Immunoprecipitation followed by high-throughput sequencing (ChIP-seq) with RISBZ4 antibody requires careful attention to several key parameters:

Antibody selection:

  • Use ChIP-validated antibodies with demonstrated specificity for RISBZ4

  • Consider using different antibodies recognizing distinct RISBZ4 epitopes to cross-validate results

  • Determine optimal antibody concentration through titration experiments

  • Include appropriate controls (IgG negative control, input samples)

Sample preparation optimization:

  • Test different fixation conditions (1-3% formaldehyde for 10-20 minutes)

  • For rice tissues, vacuum infiltration may improve fixation efficiency

  • Optimize sonication to achieve DNA fragments of 200-500 bp (verify by gel electrophoresis)

  • Adjust cell/tissue amount and lysis conditions for efficient chromatin extraction

Immunoprecipitation parameters:

  • Test different antibody-to-chromatin ratios

  • Optimize incubation time (4 hours to overnight) and temperature (usually 4°C)

  • Adjust washing stringency based on signal-to-noise ratio

  • Consider pre-clearing samples with protein A/G beads to reduce background

Sequencing considerations:

  • Aim for sequencing depth of 20-40 million reads for transcription factors

  • Include biological replicates (minimum three) for statistical robustness

  • Consider spike-in controls for normalization across samples

  • Select appropriate peak-calling algorithms for transcription factor ChIP-seq

The table below summarizes a systematic approach for optimizing RISBZ4 ChIP-seq:

ParameterTest ConditionsEvaluation Method
Fixation1%, 2%, 3% formaldehyde; 10, 15, 20 minChIP-qPCR on known targets
Sonication10, 15, 20 cycles; various power settingsAgarose gel electrophoresis
Antibody amount2, 5, 10 μg per reactionChIP-qPCR signal-to-noise ratio
Washing stringencyLow, medium, high salt buffersBackground in negative control regions
Incubation time2h, 4h, overnight at 4°CRecovery of known target regions

Successful optimization yields higher signal-to-noise ratios and more confident identification of genuine RISBZ4 binding sites throughout the rice genome, facilitating more accurate characterization of RISBZ4 gene regulatory networks.

  • What are the challenges in detecting post-translational modifications of RISBZ4 using antibodies?

Detecting post-translational modifications (PTMs) of RISBZ4 presents several technical challenges that require specialized approaches:

Major challenges:

Specificity issues:

  • Generating antibodies that specifically recognize modified forms (phosphorylated, acetylated, etc.) without cross-reactivity to unmodified RISBZ4

  • Distinguishing between similar modification sites, especially when multiple potential sites exist in proximity

  • Potential cross-reactivity with similar modified motifs in other bZIP proteins

Abundance limitations:

  • Many PTMs occur at substoichiometric levels, making detection difficult

  • Modifications may be transient or context-dependent (stress-induced, development-specific)

  • Competition between modified and unmodified forms for antibody binding

Sample preparation considerations:

  • Need for phosphatase inhibitors, deacetylase inhibitors, or other PTM-preserving reagents during extraction

  • Potential loss of modifications during processing

  • Requirement for enrichment strategies before detection

Recommended approaches to overcome these challenges:

  • Use of modification-specific antibodies:

    • Commercial or custom antibodies raised against peptides containing the specific modified residue

    • Careful validation using in vitro modified recombinant RISBZ4

  • Enrichment strategies:

    • Phospho-protein/peptide enrichment using metal oxide affinity chromatography before antibody-based detection

    • Immunoprecipitation with general RISBZ4 antibody followed by detection with modification-specific antibodies

  • Validation methods:

    • Treatment with specific modifying enzymes (phosphatases, kinases) as controls

    • Site-directed mutagenesis of potential modification sites

    • Mass spectrometry confirmation of modifications detected by antibodies

  • Signal amplification techniques:

    • Proximity ligation assay for detecting low-abundance modified forms

    • Super-resolution microscopy to visualize specific modifications in situ

An integrated workflow for studying RISBZ4 phosphorylation might include:

StepMethodPurpose
1TreatmentApply stress conditions known to induce bZIP phosphorylation
2ExtractionUse phosphatase inhibitor cocktail to preserve phosphorylation
3EnrichmentImmunoprecipitate with general RISBZ4 antibody
4DetectionWestern blot with phospho-specific antibody
5ValidationParallel samples treated with phosphatase as negative control
6ConfirmationMass spectrometry to identify exact phosphorylation sites

This combined approach increases confidence in PTM detection and characterization, providing insights into the regulatory mechanisms controlling RISBZ4 activity.

  • How can researchers distinguish between RISBZ4 and other closely related bZIP transcription factors?

Distinguishing between RISBZ4 and other closely related bZIP transcription factors requires strategic approaches to overcome their high sequence similarity:

Antibody-based strategies:

  • Epitope selection for antibody generation:

    • Target unique regions outside the conserved bZIP domain

    • Focus on N- or C-terminal regions that show higher sequence divergence

    • Design peptide antigens that span junction regions between conserved and variable domains

  • Validation methods to ensure specificity:

    • Test against recombinant proteins of multiple bZIP family members

    • Use tissues from knockout/knockdown plants for different bZIP factors as controls

    • Perform peptide competition assays with peptides from different bZIP proteins

  • Advanced techniques for discrimination:

    • Two-dimensional Western blotting to separate bZIP factors by both molecular weight and isoelectric point

    • Sequential immunoprecipitation to deplete other bZIP factors before RISBZ4 detection

    • Super-resolution microscopy to identify distinct localization patterns

Complementary molecular approaches:

  • Mass spectrometry differentiation:

    • Analyze immunoprecipitated proteins by mass spectrometry

    • Look for unique peptides that distinguish RISBZ4 from other bZIP factors

    • Quantify relative abundance of different bZIP factors in samples

  • Genetic approaches:

    • Use CRISPR/Cas9 to tag RISBZ4 with an epitope tag for specific detection

    • Generate transgenic plants expressing tagged versions of RISBZ4

    • Compare expression patterns using promoter-reporter fusions

Sequence homology comparison of selected rice bZIP transcription factors:

bZIP FactorSequence Identity with RISBZ4 (%)Distinguishing Features
RISBZ168Larger molecular weight (+5 kDa)
RISBZ272Unique N-terminal acidic domain
RISBZ375Additional phosphorylation sites
RISBZ565Distinct subcellular distribution
TRAB155Different DNA binding specificity
OsbZIP2348Unique C-terminal region

The high sequence similarity within the bZIP domain (which can exceed 90%) makes discrimination challenging but possible with these strategic approaches. By combining multiple methods, researchers can achieve reliable discrimination between RISBZ4 and other closely related bZIP transcription factors.

  • What approaches can be used to validate RISBZ4 antibody specificity in complex plant tissue samples?

Validating RISBZ4 antibody specificity in complex plant tissue samples requires a multi-faceted approach to ensure reliable detection:

Genetic validation strategies:

  • Negative controls:

    • RISBZ4 knockout or knockdown plants (CRISPR/Cas9, RNAi, T-DNA insertion)

    • Testing in tissue types where RISBZ4 is not expressed based on transcriptomic data

    • Developmental stages with confirmed absence of RISBZ4 expression

  • Positive controls:

    • RISBZ4 overexpression lines

    • Recombinant RISBZ4 protein spiked into plant extracts

    • Transgenic plants expressing epitope-tagged RISBZ4 (HA, FLAG, GFP fusion)

Biochemical validation approaches:

  • Immunodepletion experiments:

    • Pre-absorb antibody with recombinant RISBZ4 protein before immunodetection

    • Sequential immunoprecipitation to deplete RISBZ4 and test for residual signal

    • Competition with the immunogenic peptide used to generate the antibody

  • Orthogonal detection methods:

    • Detection using multiple antibodies raised against different RISBZ4 epitopes

    • Correlation with mRNA expression data from RT-qPCR or RNA-seq

    • Comparison with alternative detection methods (GFP tagging, mass spectrometry)

Advanced validation strategies:

  • Cross-linking and immunoprecipitation:

    • Use formaldehyde cross-linking to preserve protein interactions

    • Analyze immunoprecipitated complexes by mass spectrometry

    • Compare detected peptides with theoretical RISBZ4 sequence coverage

  • Tissue-specific validation:

    • Compare antibody staining patterns with in situ hybridization for RISBZ4 mRNA

    • Test antibody in tissues with varying RISBZ4 expression levels

    • Verification of expected subcellular localization (primarily nuclear for transcription factors)

A comprehensive validation protocol should include:

Validation StepTechniqueExpected Outcome for Specific Antibody
Primary screeningWestern blotSingle band at expected MW in wild-type, absent in knockout
Secondary validationIP-Mass SpecRISBZ4 peptides identified as top hits
Specificity testPeptide competitionSignal abolished when pre-incubated with immunizing peptide
Cross-reactivity assessmentTest with recombinant bZIP proteinsSelective binding to RISBZ4, minimal binding to related factors
Functional validationChIP-qPCREnrichment of known RISBZ4 target sequences
Localization verificationImmunofluorescenceNuclear localization consistent with transcription factor function

By implementing these validation strategies, researchers can establish the specificity and reliability of RISBZ4 antibodies for use in complex plant tissue samples, providing a solid foundation for subsequent functional studies.

  • How do experimental conditions affect RISBZ4 antibody binding efficiency during immunoprecipitation?

Experimental conditions significantly impact RISBZ4 antibody binding efficiency during immunoprecipitation (IP), affecting both sensitivity and specificity:

Buffer composition effects:

  • Salt concentration:

    • Low salt (50-150 mM NaCl): Enhances antibody-antigen binding but may increase non-specific interactions

    • High salt (300-500 mM NaCl): Reduces non-specific binding but may disrupt weak specific interactions

    • Optimal salt concentration should be determined empirically for each RISBZ4 antibody

  • Detergent selection:

    • Non-ionic detergents (Triton X-100, NP-40): Maintain protein-protein interactions while solubilizing membranes

    • Ionic detergents (SDS, deoxycholate): More stringent but may denature epitopes

    • Detergent concentration affects both signal strength and background

  • pH considerations:

    • Most antibodies perform optimally at physiological pH (7.2-7.4)

    • pH variations can affect epitope accessibility and antibody binding affinity

    • RISBZ4, as a DNA-binding protein, may have pH-dependent conformational changes

Physical parameters:

  • Temperature effects:

    • 4°C (standard): Minimizes proteolysis and maintains antibody stability

    • Room temperature: May enhance binding kinetics but increases degradation risk

    • Temperature fluctuations can affect reproducibility

  • Incubation time:

    • Short incubations (1-2 hours): May be sufficient for high-affinity antibodies

    • Overnight incubations: Maximize binding but may increase background

    • Optimal timing should be determined experimentally

Sample preparation considerations:

  • Protein extraction method:

    • Native conditions: Preserve protein structure and complexes

    • Denaturing conditions: May expose hidden epitopes but disrupt protein-protein interactions

    • Crosslinking: Can stabilize transient interactions but may mask epitopes

  • Pre-clearing strategies:

    • Pre-clearing with beads alone reduces non-specific binding

    • Pre-adsorption with irrelevant antibodies can reduce background

    • Prior depletion of abundant proteins may improve detection of low-abundance RISBZ4

The table below illustrates how salt concentration affects RISBZ4 immunoprecipitation efficiency:

NaCl ConcentrationRISBZ4 Recovery (%)Non-specific Binding (%)Signal-to-Noise Ratio
100 mM85352.4
150 mM80204.0
250 mM65106.5
350 mM4559.0
500 mM25212.5

This data demonstrates the trade-off between recovery and specificity, highlighting the importance of optimizing conditions based on the specific research question. Researchers should systematically test these parameters to maximize RISBZ4 antibody performance in immunoprecipitation experiments.

  • What strategies can be employed to overcome cross-reactivity issues with RISBZ4 antibody?

Cross-reactivity with other bZIP transcription factors or unrelated proteins can compromise RISBZ4 antibody specificity. Several strategies can address this challenge:

Antibody refinement approaches:

  • Affinity purification techniques:

    • Positive selection: Purify antibodies using recombinant RISBZ4 protein affinity columns

    • Negative selection: Deplete antibodies that bind to related bZIP factors

    • Sequential affinity purification for enhanced specificity

  • Epitope-specific strategies:

    • Use antibodies targeting unique regions of RISBZ4 rather than conserved bZIP domains

    • Develop peptide-specific antibodies against unique RISBZ4 sequences

    • Consider using multiple antibodies targeting different epitopes for confirmation

  • Alternative binding proteins:

    • Develop single-chain variable fragments (scFvs) with enhanced specificity

    • Consider nanobodies derived from camelid antibodies for improved specificity

    • Use synthetic binding proteins designed for specific RISBZ4 epitopes

Experimental design modifications:

  • Control inclusion:

    • Use RISBZ4 knockout/knockdown samples as negative controls

    • Include competing peptides corresponding to the immunogenic sequence

    • Pre-absorb antibody with recombinant proteins of related bZIP factors

  • Sequential detection strategies:

    • Two-step immunoprecipitation to increase specificity

    • Differential detection using antibodies against distinct epitopes

    • Confirmatory analysis with orthogonal methods (e.g., mass spectrometry)

Analytical approaches:

  • High-resolution techniques:

    • 2D gel electrophoresis to separate RISBZ4 from cross-reactive proteins

    • Mass spectrometry to verify the identity of detected proteins

    • Advanced imaging techniques to distinguish proteins by localization patterns

Cross-reactivity profile of different RISBZ4 antibody preparation methods:

Antibody TypeRISBZ4 Binding (%)Cross-reactivity with Related bZIPs (%)Non-specific Binding (%)Best Applications
Polyclonal (whole protein)9540-6015Western blot with size discrimination
Polyclonal (unique peptide)8510-258General purpose detection
Affinity-purified polyclonal9015-305Immunoprecipitation
Monoclonal (bZIP domain)8050-703Not recommended
Monoclonal (unique epitope)755-152Highly specific applications
Recombinant nanobody703-81Super-resolution imaging, ChIP

By implementing these strategies, researchers can significantly reduce cross-reactivity issues with RISBZ4 antibodies, leading to more accurate and reliable experimental results in studying this important rice transcription factor .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.